Total Payments
$1,540
2024 Payments
$30.72
Companies
22
Transactions
107
Medicare Patients
855
Medicare Billing
$72,542
Payment Breakdown by Category
Food & Beverage$1,540 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,540 | 107 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $352.55 | 32 | $0 (2023) |
| Novo Nordisk Inc | $294.54 | 20 | $0 (2023) |
| Lilly USA, LLC | $171.06 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $137.99 | 8 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $124.58 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $64.68 | 4 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $42.59 | 2 | $0 (2021) |
| PFIZER INC. | $42.20 | 2 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $40.94 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $38.16 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.72 | 2 | Boston Scientific Corporation ($16.48) |
| 2023 | $150.90 | 9 | Paratek Pharmaceuticals, Inc. ($36.80) |
| 2022 | $536.94 | 38 | ABBVIE INC. ($151.77) |
| 2021 | $821.07 | 58 | AbbVie Inc. ($186.65) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: General - Pain Management_NMD | ||||||
| 01/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Diabetes | ||||||
| 12/19/2023 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: ANTIBIOTIC | ||||||
| 07/14/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: DIABETES | ||||||
| 01/31/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: ANTIBIOTIC | ||||||
| 01/10/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Obesity | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Gastroenterology | ||||||
| 11/17/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Obesity | ||||||
| 11/14/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/10/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $2.20 | General |
| 09/29/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: Obesity | ||||||
| 09/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Gastroenterology | ||||||
| 09/07/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $14.15 | General |
| 09/01/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Respiratory | ||||||
| 08/30/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PRIMARY CARE | ||||||
| 08/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 81 | 254 | $21,666 | $7,544 |
| 2022 | 10 | 210 | 498 | $43,216 | $16,114 |
| 2021 | 10 | 239 | 666 | $66,179 | $26,354 |
| 2020 | 13 | 325 | 783 | $66,947 | $22,529 |
Total Patients
855
Total Services
2,201
Medicare Billing
$72,542
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 59 | $11,151 | $4,014 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 63 | $8,253 | $2,979 | 36.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 51 | $1,836 | $397.76 | 21.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $286.00 | $147.15 | 51.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 70 | $140.00 | $5.64 | 4.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 103 | $19,368 | $7,134 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 123 | $16,038 | $5,370 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $2,736 | $1,713 | 62.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 17 | 21 | $1,680 | $860.69 | 51.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 58 | $2,088 | $451.82 | 21.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 18 | 18 | $468.00 | $268.44 | 57.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 17 | 17 | $442.00 | $258.35 | 58.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 14 | $140.00 | $28.81 | 20.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 12 | 64 | $128.00 | $24.78 | 19.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 64 | $128.00 | $4.54 | 3.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 188 | $24,603 | $9,674 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 130 | $24,537 | $9,093 | 37.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 28 | $7,140 | $3,155 | 44.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $2,750 | $1,524 | 55.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $2,223 | $1,418 | 63.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 29 | 96 | $3,456 | $792.71 | 22.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 27 | 27 | $702.00 | $410.94 | 58.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 14 | 14 | $364.00 | $213.08 | 58.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 12 | 43 | $172.00 | $62.03 | 36.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 17 | 116 | $232.00 | $11.36 | 4.9% |
About Natalie Locklear, NP
Natalie Locklear, NP is a Family healthcare provider based in Pembroke, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2013. The National Provider Identifier (NPI) number assigned to this provider is 1083956577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Natalie Locklear, NP has received a total of $1,540 in payments from pharmaceutical and medical device companies, with $30.72 received in 2024. These payments were reported across 107 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,540).
As a Medicare-enrolled provider, Locklear has provided services to 855 Medicare beneficiaries, totaling 2,201 services with total Medicare billing of $72,542. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Pembroke, NC
- Active Since 03/22/2013
- Last Updated 09/22/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1083956577
Products in Payments
- UBRELVY (Drug) $155.84
- Ozempic (Drug) $149.66
- FARXIGA (Drug) $124.53
- VRAYLAR (Drug) $119.43
- XIFAXAN (Drug) $108.90
- JARDIANCE (Drug) $94.50
- TRULICITY (Drug) $94.11
- NURTEC ODT (Drug) $83.53
- Rybelsus (Drug) $46.52
- Saxenda (Drug) $42.55
- LINZESS (Drug) $40.50
- SOLIQUA 100/33 (Biological) $38.16
- NUZYRA (Drug) $36.80
- QULIPTA (Drug) $36.01
- EMGALITY (Drug) $32.89
- PREMARIN (Drug) $28.29
- FREESTYLE LIBRE 2 (Device) $23.74
- Vascepa (Drug) $21.95
- RYBELSUS (Drug) $20.88
- TRINTELLIX (Drug) $20.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Pembroke
Ella Lynch, Fnp-C, Pmhnp-Bc, FNP-C, PMHNP-BC
Family — Payments: $3,026
Family $3,026
Mrs. Denene Smith, Fnp, FNP
Family — Payments: $2,307
Family $2,307
Mrs. Mary Bacon, Arnp, ARNP
Family — Payments: $2,228
Family $2,228
Mrs. Katara Chavis, Fnp-C, FNP-C
Family — Payments: $1,699
Family $1,699
Mrs. Jodella Locklear, Fnp-C, FNP-C
Family — Payments: $1,260
Family $1,260
Janice Shiver, Np, NP
Family — Payments: $1,136
Family $1,136